TEVA Stock Pops 4% as Teva Receives FDA Approval

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Teva Pharmaceutical stock is rising higher on Monday after partner company Alvotech got approval from the FDA for a Humira biosimilar.

The post TEVA Stock Pops 4% as Teva Receives FDA Approval appeared first on InvestorPlace.

• ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
• “America’s Top Trader” Issues A.I. Code Red: Act Now or Miss Out
• It doesn’t matter if you have $500 or $5 million. Do this now.